Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure

Pediatric Blood and Cancer

Volumn 49, Issue 7, 2007, Pages 1025-1029

  Savage, William J ^a   Kickler, Thomas S ^b   Takemoto, Clifford M ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bleeding disorders; Hemostasis; Pediatric hematology

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 INHIBITOR; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; HEPARIN; IMMUNOGLOBULIN; PROTHROMBIN; THROMBIN; UNCLASSIFIED DRUG; VITAMIN K GROUP;

ANTICOAGULATION; ANTIGENICITY; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HEMOSTASIS; HUMAN; INFANT; MALE; PARTIAL THROMBOPLASTIN TIME; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; SCHOOL CHILD; SIDE EFFECT; THROMBIN TIME; TREATMENT OUTCOME; TRICUSPID VALVE ATRESIA;

ADMINISTRATION, TOPICAL; ANIMALS; BLOOD COAGULATION FACTOR INHIBITORS; CARDIAC SURGICAL PROCEDURES; CATTLE; CHILD; FACTOR V; FEMALE; HUMANS; IMMUNOGLOBULINS; INFANT; INJECTIONS, INTRAVENOUS; MALE; STEROIDS; THROMBIN; TRICUSPID ATRESIA; VASCULAR SURGICAL PROCEDURES;

EID: 35649020138     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20798     Document Type: Article

References (18)

1. Schoenecker JG, Hauck RK, Mercer MC, et al. Exposure to topical bovine thrombin during surgery elicits a response against the xenogeneic carbohydrate galactose alphal-3galactose. J Clin Immunol 2000;20:434-444.
2. Winterbottom N, Kuo JM, Nguyen K, et al. Antigenic responses to bovine thrombin exposure during surgery: A prospective study of 309 patients. J Appl Res 2005;2.
3. Streiff MB, Ness PM. Acquired FV inhibitors: A needless iatrogenic complication of bovine thrombin exposure. Transfusion 2002;42:18-26.
4. Muntean W, Zenz W, Finding K, et al. Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two-year-old child. Acta Paediatr 1994;83:84-87.
5. Israels SJ, Israels ED. Development of antibodies to bovine and human factor V in two children after exposure to topical bovine thrombin. Am J Pediatr Hematol Oncol 1994;16:249-254.
6. Ortel TL, Mercer MC, Thames EH, et al. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 2001;233:88-96.
7. Israels SJ, Leaker MT. Acquired inhibitors to factors V and X after exposure to topical thrombin: Interference with monitoring of low molecular weight heparin and warfarin. J Pediatr 1997;131:480-483.
8. Dimichele D, Rivard G, Hay C, et al. Inhibitors in haemophilia: Clinical aspects. Haemophilia 2004;10:140-145.
9. Gringeri A, Mannucci PM. Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors. Haemophilia 2005;11:611-619.
10. Muntean W, Zenz W, Edlinger G, et al. Severe bleeding due to factor V inhibitor after repeated operations using fibrin sealant containing bovine thrombin. Thromb Haemost 1997;77:1223.
11. Tarantino MD, Ross MP, Daniels TM, et al. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin. J Pediatr Hematol Oncol 1997;19:226-231.
12. Feinstein DI, Rapaport SI, McGehee WG, et al. Factor V anticoagulants: Clinical, biochemical, and immunological observations. J Clin Invest 1970;49:1578-1588.
13. Zehnder JL, Leung LL. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood 1990;76:2011-2016.
14. Muntean W, Zenz W, Finding K. [Acquired thrombin inhibitor in a 9-year-old child after total correction of univentricular heart with pulmonary atresia and administration of fibrin glue]. Wien Klin Wochenschr 1992;104:101-104.
15. Chediak J, Ashenhurst JB, Garlick I, et al. Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions. Blood 1980;56:835-841.
16. Ortel TL, Charles LA, Keller FG, et al. Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosis. Am J Hematol 1994;45:128-135.
17. Diez-Martin J, Sikkink RA, Gilchrist GS, et al. Development of anti-bovine thrombin antibodies following neurosurgical procedures. Br J Haematol 1990;74:369-370.
18. Flaherty MJ, Henderson R, Wener MH. Iatrogenic immunization with bovine thrombin: A mechanism for prolonged thrombin times after surgery. Ann Intern Med 1989;111:631-634.